Event Type: Conference call with Analysts/Investors on Financial Results
Financial Period Discussed: Quarter ended 30th June 2026 (Q1 FY27)
Recording Availability: Audio recording has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording30062026.mp3
Regulatory Compliance: Disclosure made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Continuation: This disclosure is in continuation of the company's letter dated 17th July, 2026
Additional Notes Section
Management Participants: Not specified in this disclosure
Financial Data Disclosure: No financial figures or results data included in this announcement
Presentation Materials: No mention of presentation decks, transcripts, or supplementary materials
Compliance Language: No specific statement regarding unpublished price sensitive information (UPSI) in this disclosure
